Dual antiplatelet therapy (DAPT) consisting of aspirin plus a P2Y 12 inhibitor has been the standard of care to prevent thrombotic events in patients with acute coronary syndrome (ACS) undergoing ...

BASEL, Switzerland—Low-dose colchicine doesn’t significantly reduce MACE in patients who have had a nonsevere ischemic stroke or high-risk TIA, according to the results of the CONVINCE trial. Through ...

IMPROVEMENT from colchicine therapy in patients with arthritic symptoms has always been accepted as indicative of gout. 1–3 Other arthritides supposedly have not responded satisfactorily to this ...

Please provide your email address to receive an email when new articles are posted on . In the research summary written on behalf of the LoDoCo2 Steering Committee, researchers said the self-assembly ...

Colchicine is a generic prescription medication used to prevent gout flares and treat familial Mediterranean fever (FMF) in adults and certain children. Like most drugs, colchicine can cause side ...

Please provide your email address to receive an email when new articles are posted on . A cost analysis of findings from the COLCOT trial showed that the addition of low-dose colchicine therapy to ...

Low-dose colchicine not only lowers the risk of ischemic CV events post-MI, it also can do so cost-effectively, according to the latest numbers from COLCOT. This is true from the perspective of the ...

Colchicine oral tablet is available as both a generic and brand-name drug. Brand name Colcrys. It also comes in capsules that are also available as both a generic and brand-name drug. Brand name: ...